Literature DB >> 31646531

At the Crossing of ER Stress and MAMs: A Key Role of Sigma-1 Receptor?

Benjamin Delprat1, Lucie Crouzier2, Tsung-Ping Su3, Tangui Maurice2.   

Abstract

Calcium exchanges and homeostasis are finely regulated between cellular organelles and in response to physiological signals. Besides ionophores, including voltage-gated Ca2+ channels, ionotropic neurotransmitter receptors, or Store-operated Ca2+ entry, activity of regulatory intracellular proteins finely tune Calcium homeostasis. One of the most intriguing, by its unique nature but also most promising by the therapeutic opportunities it bears, is the sigma-1 receptor (Sig-1R). The Sig-1R is a chaperone protein residing at mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs), where it interacts with several partners involved in ER stress response, or in Ca2+ exchange between the ER and mitochondria. Small molecules have been identified that specifically and selectively activate Sig-1R (Sig-1R agonists or positive modulators) at the cellular level and that also allow effective pharmacological actions in several pre-clinical models of pathologies. The present review will summarize the recent data on the mechanism of action of Sig-1R in regulating Ca2+ exchanges and protein interactions at MAMs and the ER. As MAMs alterations and ER stress now appear as a common track in most neurodegenerative diseases, the intracellular action of Sig-1R will be discussed in the context of the recently reported efficacy of Sig-1R drugs in pathologies like Alzheimer's disease, Parkinson's disease, Huntington's disease, or amyotrophic lateral sclerosis.

Entities:  

Keywords:  Addiction; Alzheimer’s disease; Amyotrophic lateral sclerosis; Calcium; ER stress; MAMs; Mitochondria; Neurodegenerative disease; Pain; Sigma-1 receptor; UPR

Mesh:

Substances:

Year:  2020        PMID: 31646531     DOI: 10.1007/978-3-030-12457-1_28

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  18 in total

1.  Evaluation of [18F]F-TZ3108 for PET Imaging of Metabolic-Associated Fatty Liver Disease.

Authors:  Peiyi Huang; Zhijun Li; Tukang Peng; Jihua Yang; Lei Bi; Guolong Huang; Yifan Qiu; Min Yang; Peizhen Ye; Mingxing Huang; Hongjun Jin; Liao Sun
Journal:  Mol Imaging Biol       Date:  2022-06-15       Impact factor: 3.488

2.  Comprehensive Preclinical Assessment of Sensory, Functional, Motivational-Affective, and Neurochemical Outcomes in Neuropathic Pain: The Case of the Sigma-1 Receptor.

Authors:  Beatriz de la Puente; Daniel Zamanillo; Luz Romero; Alicia Carceller; José Miguel Vela; Manuel Merlos; Enrique Portillo-Salido
Journal:  ACS Pharmacol Transl Sci       Date:  2022-03-17

3.  Generation of Sigmar1 conditional knockout mouse using CRISPR-Cas9 gene targeting.

Authors:  Liang Huang; Haiyan Xiao; Xiaoling Xie; Fang Hu; Fulei Tang; Sylvia B Smith; Lin Gan
Journal:  Genesis       Date:  2022-05-28       Impact factor: 2.389

4.  Sigma-1 Receptor Ligands Chlorpromazine and Trifluoperazine Attenuate Ca2+ Responses in Rat Peritoneal Macrophages.

Authors:  L S Milenina; Z I Krutetskaya; V G Antonov; N I Krutetskaya
Journal:  Cell tissue biol       Date:  2022-05-27

Review 5.  Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development.

Authors:  Peng Ren; Jingya Wang; Nanxi Li; Guangxiang Li; Hui Ma; Yongqi Zhao; Yunfeng Li
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

6.  Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models.

Authors:  Lucie Crouzier; Alberto Danese; Yuko Yasui; Elodie M Richard; Jean-Charles Liévens; Simone Patergnani; Simon Couly; Camille Diez; Morgane Denus; Nicolas Cubedo; Mireille Rossel; Marc Thiry; Tsung-Ping Su; Paolo Pinton; Tangui Maurice; Benjamin Delprat
Journal:  Sci Transl Med       Date:  2022-02-09       Impact factor: 19.319

Review 7.  Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases.

Authors:  Ning-Hua Wu; Yu Ye; Bin-Bin Wan; Yuan-Dong Yu; Chao Liu; Qing-Jie Chen
Journal:  Mol Neurobiol       Date:  2021-08-12       Impact factor: 5.590

8.  The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains.

Authors:  Vladimir Zhemkov; Jonathon A Ditlev; Wan-Ru Lee; Mikaela Wilson; Jen Liou; Michael K Rosen; Ilya Bezprozvanny
Journal:  Elife       Date:  2021-05-11       Impact factor: 8.140

9.  Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole.

Authors:  Mikhail V Voronin; Yulia V Vakhitova; Inna P Tsypysheva; Dmitry O Tsypyshev; Inna V Rybina; Rustam D Kurbanov; Elena V Abramova; Sergei B Seredenin
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

10.  Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R).

Authors:  Giacomo Rossino; Marta Rui; Luca Pozzetti; Dirk Schepmann; Bernhard Wünsch; Daniele Zampieri; Giorgia Pellavio; Umberto Laforenza; Silvia Rinaldi; Giorgio Colombo; Laura Morelli; Pasquale Linciano; Daniela Rossi; Simona Collina
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.